China SXT Pharmaceuticals, Inc. Announces Filing of Annual Report on Form 20-F for Year Ended March 31, 2019

TAIZHOU, China, Aug. 19, 2019 /PR Newswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company......

China SXT Pharmaceuticals, Inc. Receives New Pharmaceutical GMP Certificate

TAIZHOU, China, Aug. 12, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focus......

China SXT Pharmaceuticals, Inc. Announces Pricing of a $15 Million PIPE Financing

TAIZHOU, China, April 17, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company......

China SXT Pharmaceuticals, Inc. Receives National High-tech Enterprise Qualification

TAIZHOU, China, Apr. 2, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc.  (the "Company") (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the rese......

China SXT Pharmaceuticals, Inc. Announces Financial Results for the Six Months Ended September 30, 2018

TAIZHOU, China, March 28, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc.  (the "Company") (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the re......

China SXT Pharmaceuticals, Inc. Announces Final Closing of Initial Public Offering

TAIZHOU, China and NEW YORK, Jan. 4, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (the "Company") (NASDAQ: SXTC), a specialty pharmaceutical company foc......

China SXT Pharmaceuticals, Inc. Announces First Closing of Initial Public Offering

TAIZHOU, China and New York, Jan. 2, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc.  (the "Company") (NASDAQ:SXTC), a specialty pharmaceutical company foc......

China SXT Pharmaceuticals, Inc. Announces Effectiveness of Registration Statement on Form F-1 and Pricing the Initial Public Offering of its Ordinary Shares at $4.00 per Share

TAIZHOU, China, Sept. 28, 2018 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (the "Company"), a specialty pharmaceutical company focusing on the research, development, manuf......

2018-09-15： Research and Development of Innovative New Advanced TCMP

News from China SXT: Dr. Jingzhen Deng, the Chief Executive Officer and Chief Scientific Officer of Jiangsu SXT Pharmaceutical Co., Ltd., was invited for giving a special talk about “Researc......